Novavax, Inc. (NVAX) Tops Q4 EPS by 7c
Novavax, Inc. (N
ASDAQ: NVAX) reported Q4 EPS of $0.03, $0.07 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $5.85 million versus the consensus estimate of $6.87 million.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
ASDAQ: NVAX) reported Q4 EPS of $0.03, $0.07 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $5.85 million versus the consensus estimate of $6.87 million.For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.